Medication info
Amoxicillin Tablets 625 mg (Amoxicillin Hydrate · Clavulanic Acid Potassium (4:1))

Amoxicillin Tablets 625 mg (Amoxicillin Hydrate · Clavulanic Acid Potassium (4:1))

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
Oval film-coated tablet that is white or almost white
Packaging
40 tablets (4 tablets/PTP x 10)
Approval status
Active

MFDS item code 201307131 · Approved 2013.04.30 · Insurance code 671805450

Summary

Main use
Treatment of respiratory and ear, nose, and throat infections; genitourinary, skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this drug should be determined according to the patient's age, body weight, renal function, and severity of infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. ○ Adults and children 12 years or older or weighing 40 kg or more: The usual dose is 250 mg/125 mg of amoxicillin/potassium clavulanate per dose, administered orally 3 times daily every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. ○ For patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. - Adults: Dosage adjustment is based on the maximum recommended dose of amoxicillin. No dosage adjustment is required for patients with creatinine clearance (CrCl) of 30 mL/min or more. 10 ~ 30 mL/min Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis (because serum concentrations of both amoxicillin and clavulanic acid decrease).
Child dose
- Children: Reduce the dose in the same manner.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of respiratory and ear, nose, and throat infections; genitourinary, skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar pneumonia
  • bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infection
View approved original text

This medication is effective against a variety of bacterial infections and is used for respiratory infections such as acute and chronic bronchitis, pneumonia, empyema, lung abscess, tonsillitis, sinusitis, and otitis media. It also has therapeutic effects on urinary tract infections such as cystitis, urethritis, and pyelonephritis, on sexually transmitted infections such as pelvic inflammatory disease and gonorrhea, as well as on skin and soft tissue infections like boils, abscesses, cellulitis, and wound infections. Additionally, it is utilized for the treatment of osteomyelitis and dental infections, improving a wide range of infectious diseases.

How to take

Adult dose

The dose of this drug should be determined according to the patient's age, body weight, renal function, and severity of infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. ○ Adults and children 12 years or older or weighing 40 kg or more: The usual dose is 250 mg/125 mg of amoxicillin/potassium clavulanate per dose, administered orally 3 times daily every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. ○ For patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. - Adults: Dosage adjustment is based on the maximum recommended dose of amoxicillin. No dosage adjustment is required for patients with creatinine clearance (CrCl) of 30 mL/min or more. 10 ~ 30 mL/min Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 12 hours. 10 mL/min or less Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours. Hemodialysis Administer 250mg/125mg or 500mg/125mg of amoxicillin/potassium clavulanate per dose every 24 hours, with an additional dose during dialysis and a repeat dose at the end of dialysis (because serum concentrations of both amoxicillin and clavulanic acid decrease).

Child dose

- Children: Reduce the dose in the same manner.

Precautions

This medication should not be used in patients who have had specific allergic reactions. Caution must be taken especially in patients who have had hypersensitivity reactions to beta-lactam antibiotics, as the administration of this medication can lead to severe allergic reactions. Patients with poor liver function or moderate to severe kidney impairment should use this medication cautiously, adjusting the dosage and administration interval as it may strain the liver and kidneys. During the course of this medication, gastrointestinal symptoms may occur, such as diarrhea or abdominal pain, which in severe cases can progress to serious conditions like pseudomembranous colitis, necessitating immediate cessation of use and consultation with healthcare professionals if symptoms worsen. Rarely, symptoms of liver dysfunction may also arise, so regular liver function tests should be conducted, and the drug must be stopped if abnormalities are detected. Allergic reactions such as skin rash, itching, or severe skin reactions can occur; if these symptoms arise, the medication should be discontinued and the doctor notified immediately. Blood-related abnormalities such as leukopenia and thrombocytopenia may occur with long-term use, necessitating regular blood tests. Central nervous system symptoms such as dizziness, headaches, and seizures have been rarely reported, particularly in patients with poor kidney function or those on high doses, warranting caution. Pregnant or breastfeeding women should administer this medication only under medical supervision as its safety has not been fully established, and especially during early pregnancy, use should be avoided. This medication can interact with other drugs; therefore, consultation with a doctor or pharmacist is necessary when used in conjunction with anticoagulants, anti-inflammatory drugs, or oral contraceptives. In cases of overdose, gastrointestinal symptoms, impaired kidney function, and central nervous system abnormalities may manifest, requiring immediate medical attention for appropriate treatment. This medication should be stored in a cool, dry place below 25 degrees Celsius, and prior to administration, the allergy history and current medications must be verified.

Side effects

Diarrhea, pseudomembranous colitis, dyspepsia, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, loss of appetite, abdominal pain, abdominal distension, constipation, colonic pain, hyperacidity, soft stool, dry mouth, acute pancreatitis, candidiasis, antibiotic-induced colitis, severe colitis with hematochezia, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, vesiculobullous dermatitis, acute generalized exanthematous pustulosis, drug reaction associated with eosinophilia and systemic symptoms, angioedema, anaphylaxis, serum sickness syndrome, hypersensitivity vasculitis, respiratory distress with bronchospasm, laryngeal edema, anaphylactic shock, reversible leukopenia, reversible thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, mucosal candidiasis, vaginal itching, vaginal burning, increased discharge, restlessness, anxiety, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, seizures, anticholinergic effects, fever, clouding of consciousness, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, symptoms of vitamin K deficiency, symptoms of vitamin B complex deficiency, linear IgA disease, taste disturbances, malaise, dermatitis, oral edema, gastric pain, fluid and electrolyte imbalance, rash, hyperactivity, drowsiness, renal failure, interstitial cerebral convulsions, hypersensitivity shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is contained in special packaging to prevent moisture exposure and should be stored at a cool temperature between 1 to 25 degrees Celsius. Storing it this way helps maintain the drug's efficacy and prevents deterioration.

Appearance and packaging

Appearance

Oval film-coated tablet that is white or almost white

Package unit

40 tablets (4 tablets/PTP x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.